Joseph M Unger Selected Research

Immunologic Factors (Immunomodulators)

1/2023

Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph M Unger Research Topics

Disease

37	Neoplasms (Cancer) 03/2024 - 02/2002
28	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2008
13	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 07/2004
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2015 - 09/2003
7	Pain (Aches) 11/2022 - 10/2015
7	Arthralgia (Joint Pain) 11/2022 - 06/2015
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2014 - 06/2004
5	Melanoma (Melanoma, Malignant) 01/2023 - 02/2002
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2021
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 07/2013
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2013 - 09/2003
4	Lung Neoplasms (Lung Cancer) 11/2023 - 07/2020
4	Lymphoma (Lymphomas) 10/2023 - 06/2004
3	Chronic Disease (Chronic Diseases) 01/2023 - 07/2013
3	Fatigue 01/2021 - 07/2013
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015 - 06/2004
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2019
2	Osteoarthritis 12/2021 - 10/2015
2	Disease Progression 09/2021 - 10/2013
2	Neoplasm Metastasis (Metastasis) 02/2021 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2017
2	Hepatitis B 10/2019 - 10/2019
2	Hodgkin Disease (Hodgkin's Disease) 01/2017 - 08/2003
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2023
1	Diarrhea 01/2023
1	HIV Infections (HIV Infection) 01/2023
1	Virus Diseases (Viral Diseases) 12/2022
1	Osteonecrosis (Kienbock's Disease) 02/2021
1	Multiple Myeloma 01/2021
1	Exanthema (Rash) 07/2020
1	Premature Menopause 01/2019
1	Obesity 01/2019
1	Osteoporosis 01/2019

Drug/Important Bio-Agent (IBA)

10	Aromatase InhibitorsIBA 11/2022 - 06/2015
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 09/2003
7	Hormones (Hormone)IBA 01/2023 - 05/2009
7	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 09/2003
7	Prednisone (Sone)FDA LinkGeneric 01/2017 - 09/2003
6	taxaneIBA 01/2020 - 07/2013
6	Vincristine (Oncovin)FDA LinkGeneric 01/2015 - 09/2003
5	VaccinesIBA 10/2019 - 04/2002
5	Rituximab (Mabthera)FDA Link 12/2013 - 05/2008
4	IpilimumabIBA 11/2023 - 09/2021
4	Finasteride (Propecia)FDA LinkGeneric 11/2018 - 07/2004
4	Etoposide (VP 16)FDA LinkGeneric 01/2013 - 11/2005
3	NivolumabIBA 11/2023 - 09/2021
3	salicylhydroxamic acid (SHAM)IBA 11/2022 - 06/2015
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018 - 01/2015
2	InterferonsIBA 01/2023 - 11/2005
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 07/2020
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 01/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 12/2017
2	Goserelin (Zoladex)FDA Link 01/2019 - 01/2015
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2019 - 01/2018
2	Estrogen ReceptorsIBA 01/2019 - 01/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 01/2018
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2018 - 10/2015
2	Tamoxifen FDA LinkGeneric 01/2017 - 01/2016
2	Docetaxel (Taxotere)FDA Link 01/2017 - 02/2015
2	AndrogensIBA 05/2016 - 04/2016
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2014 - 04/2002
2	Histocompatibility Antigens Class IIBA 10/2014 - 04/2002
2	MelacineIBA 10/2014 - 04/2002
2	Bevacizumab (Avastin)FDA Link 08/2012 - 05/2009
2	Methotrexate (Mexate)FDA LinkGeneric 01/2009 - 11/2005
2	ParaffinIBA 10/2008 - 10/2007
2	IodineIBA 09/2006 - 09/2003
2	DNA (Deoxyribonucleic Acid)IBA 06/2004 - 02/2002
2	Cancer VaccinesIBA 04/2002 - 04/2002
1	Vitamin E FDA LinkGeneric 01/2023
1	SeleniumIBA 01/2023
1	pembrolizumabIBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 12/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	PlatinumIBA 09/2021
1	Zoledronic Acid (Zometa)FDA Link 02/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	AntioxidantsIBA 10/2020
1	AcidsIBA 01/2020
1	GangliosidesIBA 01/2020
1	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 10/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	CalciumIBA 01/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019

Therapy/Procedure

34	Therapeutics 11/2023 - 04/2002
24	Drug Therapy (Chemotherapy) 01/2023 - 02/2002
8	Immunotherapy 11/2023 - 04/2002
5	Radiotherapy 01/2015 - 09/2003
4	Adjuvant Chemotherapy 01/2020 - 03/2008
3	Aftercare (After-Treatment) 01/2023 - 01/2020
3	Chemoprevention 01/2018 - 12/2003
2	Castration 01/2017 - 02/2015
2	Stem Cell Transplantation 10/2013 - 04/2008
1	Length of Stay 03/2024
1	Continuity of Patient Care 01/2023
1	Dental Care 02/2021